146 related articles for article (PubMed ID: 93540)
1. Vinblastine, methotrexate, bleomycin, in the management of head and neck cancer.
Vanhaelen C; Bertrand M; De Jager R; Kenis Y
Eur J Cancer (1965); 1979 Nov; 15(11):1315-8. PubMed ID: 93540
[No Abstract] [Full Text] [Related]
2. Chemotherapy in recurrent heat and neck cancer.
Simmonds WP
Otolaryngol Clin North Am; 1974 Feb; 7(1):205-15. PubMed ID: 4130287
[No Abstract] [Full Text] [Related]
3. Combined chemotherapy of head and neck squamous cell carcinomas with methotrexate, bleomycin, and hydroxyurea.
Medenica R; Alberto P; Lehmann W
Cancer Chemother Pharmacol; 1981; 5(3):145-9. PubMed ID: 6170472
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of epidermoid head and neck cancer with cisplatinum/bleomycin vs methotrexate/vindesine].
Schröder M; von Heyden HW; Beyer JH; Klee M
Laryngol Rhinol Otol (Stuttg); 1981 Jun; 60(6):331-3. PubMed ID: 6167831
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for head and neck cancer. Comparison of cisplatin + vinblastine + bleomycin versus methotrexate.
Williams SD; Velez-Garcia E; Essessee I; Ratkin G; Birch R; Einhorn LH
Cancer; 1986 Jan; 57(1):18-23. PubMed ID: 2416423
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary results of a chemotherapy study of patients with squamous cell carcinoma in the head and neck region. Comparison of 2 therapeutic regimens: cis-diamminodichloroplatinum (II) and bleomycin compared to methotrexate and vindesine].
von Heyden HW; Beyer JH; Matthaei A; Nagel GA; Schröder M
Onkologie; 1981 Dec; 4(6):296-9. PubMed ID: 6175933
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of squamous cell carcinoma of the head and neck.
Greenberg BR
Ariz Med; 1985 Jul; 42(7):411-7. PubMed ID: 2412534
[No Abstract] [Full Text] [Related]
8. Loco-regional localization pattern of head and neck tumors treated with general chemotherapy (methotrexate and bleomycin).
Calciati A; Bumma C; La Grotta G; Gino GC; Falda M
Panminerva Med; 1976; 18(5-6):177-9. PubMed ID: 57586
[No Abstract] [Full Text] [Related]
9. A randomized pilot study comparing two regimens in the treatment of squamous cell carcinoma.
Moseley HS; Sasaki T; McConnell DB; Merhoff GC; Wilson WL; Grage TB; Wiess AJ; Fletcher WS
J Surg Oncol; 1976; 8(1):35-42. PubMed ID: 55523
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck.
Caradonna R; Paladine W; Ruckdeschel JC; Goldstein JC; Olson JE; Jaski JW; Silvers SA; Hillinger S; Horton J
Cancer Treat Rep; 1979 Mar; 63(3):489-91. PubMed ID: 85494
[No Abstract] [Full Text] [Related]
11. Chemotherapy in head and neck cancer.
Hong WK; Bromer R
N Engl J Med; 1983 Jan; 308(2):75-9. PubMed ID: 6183588
[No Abstract] [Full Text] [Related]
12. The chemotherapy of head and neck cancer.
Carter SK
Semin Oncol; 1977 Dec; 4(4):413-24. PubMed ID: 74095
[No Abstract] [Full Text] [Related]
13. Phase-II study of cis-diammine-dichloro platinum (cis-platinum), bleomycin and methotrexate for advanced squamous cell carcinoma of head and neck.
Espana P; Smith F; Abrams J; Haidak D; Ueno W; Woolley P; Schein P
Cancer Chemother Pharmacol; 1984; 12(2):98-100. PubMed ID: 6199132
[TBL] [Abstract][Full Text] [Related]
14. Synchronous multiple drug chemotherapy and radiotherapy for advanced (stage III and IV) squamous carcinoma of the head and neck.
Clifford P; O'Connor AD; Durden-Smith J; Hollis BA; Edwards WG; Dalley VM
Antibiot Chemother (1971); 1978; 24():60-72. PubMed ID: 77659
[No Abstract] [Full Text] [Related]
15. Sequential combination chemotherapy for advanced, recurrent, squamous carcinoma of the head and neck.
Livingston RB; Einhorn LH; Burgess MA; Gottlieb JA
Cancer Treat Rep; 1976 Jan; 60(1):103-5. PubMed ID: 63330
[No Abstract] [Full Text] [Related]
16. Vinblastine, bleomycin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck.
Perry DJ; Weltz MD; Brown AW; Henderson RL; Neglia WJ; Berenberg JL
Cancer; 1982 Dec; 50(11):2257-60. PubMed ID: 6182971
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Gebbia V; Valenza R; Testa A; Borsellino N; Cannata G; Restivo S; Speciale R; Ingria F; Spadafora G; Gebbia N
ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):279-82. PubMed ID: 7526312
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
[TBL] [Abstract][Full Text] [Related]
19. Results of a low-dose combination chemotherapy with vincristine, bleomycin and methotrexate (V-B-M) based on cell kinetics in the palliative treatment of head and neck squamous cell carcinoma.
Molinari R; Mattavelli F; Cantù G; Chiesa F; Costa L; Tancini G
Eur J Cancer (1965); 1980 Apr; 16(4):469-72. PubMed ID: 6156839
[No Abstract] [Full Text] [Related]
20. Randomized comparison of cis-diamminedichloroplatinum versus cis-diamminedichloroplatinum, methotrexate, and bleomycin in recurrent squamous cell carcinoma of the head and neck.
Davis S; Kessler W
Cancer Chemother Pharmacol; 1979; 3(1):57-9. PubMed ID: 93988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
